“1H Magnetic Resonance Spectroscopy Assessment of the Effects of Rivastigmine on Patients With Moderate Alzheimer Disease”. VITAE Academia Biomédica Digital 3, no. 24 (July 17, 2025). Accessed December 6, 2025. http://190.169.167.164/ojs-3.4.0-8/index.php/vitae/article/view/391.